Pharmacy

A first-of-its-kind proposal to create a prescription drug affordability board in Maryland advanced last week after a Maryland House committee overwhelmingly voted in favor of it, according to The Baltimore Sun.

Lawmakers in Texas have proposed two bills that would allow physicians to sell certain medications from their offices in the state, according to a KVEO TV news report.

CVS Health sent letters to 60 drugmakers asking them not to increase the net costs of their drugs in response to a proposed rule that would overhaul the rebate system, according to an Inside Drug Pricing news report.

An HHS official said the agency plans to finalize its proposed rule that would overhaul the rebate system in less than three months, according to Politico's Prescription Pulse newsletter.

OxyContin maker Purdue Pharma and the billionaire Sackler family will pay $270 million to resolve Oklahoma's claims that the company helped fuel the opioid epidemic, according to Reuters.

Thermo Fisher Scientific will buy Brammer Bio for $1.7 billion, making it the latest company jumping into the fast-growing, potentially lucrative field of gene therapy.

The Sackler Trust, run by members of the billionaire family who own OxyContin maker Purdue Pharma, will suspend all new philanthropic giving amid claims that the family played a role in fueling the U.S. opioid crisis, according to a statement…

This year, Horizon Pharma's osteopetrosis drug Actimmune tops GoodRx's list of the 20 most expensive drugs in the U.S., with a list price of $52,322 per month.

Last week, Biogen and Eisai halted two phase 3 clinical trials of its once-promising Alzheimer's disease drug, leading many people to ask — what now?

Tufts University has hired Donald Stern, a former U.S. attorney, to investigate its ties to Purdue Pharma and the billionaire family that owns the OxyContin maker, according to STAT.